Alimera Sciences Inc has a consensus price target of $8, established from looking at the 14 latest analyst ratings. The last 3 analyst ratings were released from Maxim Group, HC Wainwright & Co., and HC Wainwright & Co. on March 25, 2024, March 8, 2024, and August 14, 2023. With an average price target of $7 between Maxim Group, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 105.88% upside for Alimera Sciences Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/25/2024 | ALIM | Buy Now | Alimera Sciences | $3.40 | 194.12% | Maxim Group | Naz Rahman | → $10 | Initiates | → Buy | Get Alert |
03/08/2024 | ALIM | Buy Now | Alimera Sciences | $3.40 | 76.47% | HC Wainwright & Co. | Yi Chen | $5 → $6 | Maintains | Buy | Get Alert |
08/14/2023 | ALIM | Buy Now | Alimera Sciences | $3.40 | 47.06% | HC Wainwright & Co. | Yi Chen | → $5 | Reiterates | Buy → Buy | Get Alert |
06/12/2023 | ALIM | Buy Now | Alimera Sciences | $3.40 | 135.29% | Alliance Global Partners | James Molloy | $4.5 → $8 | Upgrade | Neutral → Buy | Get Alert |
05/25/2023 | ALIM | Buy Now | Alimera Sciences | $3.40 | 47.06% | HC Wainwright & Co. | Yi Chen | → $5 | Reiterates | Buy → Buy | Get Alert |
05/19/2023 | ALIM | Buy Now | Alimera Sciences | $3.40 | 47.06% | HC Wainwright & Co. | Yi Chen | $9 → $5 | Maintains | Buy | Get Alert |
05/16/2023 | ALIM | Buy Now | Alimera Sciences | $3.40 | 164.71% | HC Wainwright & Co. | Yi Chen | → $9 | Reiterates | Buy → Buy | Get Alert |
04/03/2023 | ALIM | Buy Now | Alimera Sciences | $3.40 | 164.71% | HC Wainwright & Co. | Yi Chen | → $9 | Reiterates | → Buy | Get Alert |
02/23/2023 | ALIM | Buy Now | Alimera Sciences | $3.40 | 164.71% | HC Wainwright & Co. | Yi Chen | → $9 | Reiterates | → Buy | Get Alert |
11/21/2022 | ALIM | Buy Now | Alimera Sciences | $3.40 | 32.35% | Alliance Global Partners | James Molloy | $11 → $4.5 | Downgrade | Buy → Neutral | Get Alert |
07/28/2022 | ALIM | Buy Now | Alimera Sciences | $3.40 | 164.71% | HC Wainwright & Co. | Yi Chen | $8 → $9 | Maintains | Buy | Get Alert |
05/10/2022 | ALIM | Buy Now | Alimera Sciences | $3.40 | 135.29% | HC Wainwright & Co. | Yi Chen | $10 → $8 | Maintains | Buy | Get Alert |
02/25/2022 | ALIM | Buy Now | Alimera Sciences | $3.40 | 194.12% | HC Wainwright & Co. | Yi Chen | $12 → $10 | Maintains | Buy | Get Alert |
08/16/2021 | ALIM | Buy Now | Alimera Sciences | $3.40 | 252.94% | HC Wainwright & Co. | Yi Chen | — | Maintains | Buy | Get Alert |
The latest price target for Alimera Sciences (NASDAQ: ALIM) was reported by Maxim Group on March 25, 2024. The analyst firm set a price target for $10.00 expecting ALIM to rise to within 12 months (a possible 194.12% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for Alimera Sciences (NASDAQ: ALIM) was provided by Maxim Group, and Alimera Sciences initiated their buy rating.
The last upgrade for Alimera Sciences Inc happened on June 12, 2023 when Alliance Global Partners raised their price target to $8. Alliance Global Partners previously had a neutral for Alimera Sciences Inc.
The last downgrade for Alimera Sciences Inc happened on November 21, 2022 when Alliance Global Partners changed their price target from $11 to $4.5 for Alimera Sciences Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alimera Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alimera Sciences was filed on March 25, 2024 so you should expect the next rating to be made available sometime around March 25, 2025.
While ratings are subjective and will change, the latest Alimera Sciences (ALIM) rating was a initiated with a price target of $0.00 to $10.00. The current price Alimera Sciences (ALIM) is trading at is $3.40, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.